The idea of printing replacement biological tissue and organs has been around for a while – we mentioned the development the pressure-assisted spinning system back in 2007, in fact – but it looks like it’s finally reached the point where people think they can make a profit from it on a commercial scale. Via io9, The Economist tells us about Organovo and their US$200,000-a-pop commercially-available bio-printer:
To start with, only simple tissues, such as skin, muscle and short stretches of blood vessels, will be made, says Keith Murphy, Organovo’s chief executive, and these will be for research purposes. Mr Murphy says, however, that the company expects that within five years, once clinical trials are complete, the printers will produce blood vessels for use as grafts in bypass surgery. With more research it should be possible to produce bigger, more complex body parts. Because the machines have the ability to make branched tubes, the technology could, for example, be used to create the networks of blood vessels needed to sustain larger printed organs, like kidneys, livers and hearts.
I can’t wait to see what uses the street will find for this technology once it gets cheaper…
… no, scratch that. I think maybe I can wait after all.